Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.

Neuro-oncology
Gabriel A Bien-WillnerArie Perry

Abstract

Medulloblastoma is diagnosed histologically; treatment depends on staging and age of onset. Whereas clinical factors identify a standard- and a high-risk population, these findings cannot differentiate which standard-risk patients will relapse and die. Outcome is thought to be influenced by tumor subtype and molecular alterations. Poor prognosis has been associated with isochromosome (i)17q in some but not all studies. In most instances, molecular investigations document that i17q is not a true isochromosome but rather an isodicentric chromosome, idic(17)(p11.2), with rearrangement breakpoints mapping within the REPA/REPB region on 17p11.2. This study explores the clinical utility of testing for idic(17)(p11.2) rearrangements using an assay based on fluorescent in situ hybridization (FISH). This test was applied to 58 consecutive standard- and high-risk medulloblastomas with a 5-year minimum of clinical follow-up. The presence of i17q (ie, including cases not involving the common breakpoint), idic(17)(p11.2), and histologic subtype was correlated with clinical outcome. Overall survival (OS) and disease-free survival (DFS) were consistent with literature reports. Fourteen patients (25%) had i17q, with 10 (18%) involving the comm...Continue Reading

References

Nov 1, 1989·Genes, Chromosomes & Cancer·J A BiegelB S Emanuel
Jul 1, 1996·Journal of Neuro-oncology·P H Cogen, J D McDonald
Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W G ScheurlenJ Kühl
Aug 26, 1998·Neuropathology and Applied Neurobiology·M T GiordanaE Pavanelli
Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P M ZeltzerR J Packer
Jun 24, 1999·Genes, Chromosomes & Cancer·W G ScheurlenO A Haas
Apr 12, 2000·Journal of Neuropathology and Experimental Neurology·C G EberhartP C Burger
Nov 18, 2000·Journal of Neuropathology and Experimental Neurology·H G BrownP C Burger
Apr 18, 2001·Current Opinion in Oncology·J G Gurney, N Kadan-Lottick
Jul 4, 2001·International Journal of Cancer. Journal International Du Cancer·A KochT Pietsch
Sep 5, 2001·British Journal of Cancer·R GilbertsonD Ellison
Jan 5, 2002·Brain Pathology·Christine E Fuller, Arie Perry
Mar 20, 2002·Cancer·Charles G EberhartPeter C Burger
Aug 15, 2002·Neuropathology and Applied Neurobiology·D Ellison
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger E TaylorUNKNOWN United Kingdom Children's Cancer Study Group
Aug 30, 2003·Brain Pathology·Charles G Eberhart, Peter C Burger
Feb 7, 2004·Human Molecular Genetics·Christine J Shaw, James R Lupski
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jayne M LamontDavid W Ellison
Sep 24, 2004·International Journal of Radiation Oncology, Biology, Physics·Regina I JakackiRobert Timmerman
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edward PanBurt G Feuerstein
Jul 27, 2005·American Journal of Hematology·Gabriel A Bien-WillnerGopalrao V N Velagaleti
Aug 2, 2005·The Lancet Oncology·Jacques GrillUNKNOWN French Society of Paediatric Oncology
Oct 20, 2005·Journal of Bioscience and Bioengineering·Yoshiteru Aoi
Jan 19, 2006·Genes, Chromosomes & Cancer·Frank MendrzykBernhard Radlwimmer
Jun 20, 2006·Journal of Neuropathology and Experimental Neurology·Martin Gerard McCabeVincent Peter Collins
Jul 21, 2006·Journal of Neuro-oncology·Sarah E SquireKaren J Marcus
Sep 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger J PackerRichard Sposto
Apr 28, 2007·Nature Clinical Practice. Oncology·William R Polkinghorn, Nancy J Tarbell
Nov 28, 2007·Annual Review of Pathology·Richard J Gilbertson, David W Ellison
Aug 21, 2008·Genome Research·Claudia M B Carvalho, James R Lupski
Nov 1, 2008·Genes, Chromosomes & Cancer·Martin G McCabeV Peter Collins
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan PfisterAndrey Korshunov
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria Luisa GarrèTorsten Pietsch
Sep 9, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul A NorthcottMichael D Taylor
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W EllisonSteven C Clifford
Jan 27, 2011·Acta Neuropathologica·David W EllisonRichard J Gilbertson
Jul 27, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinUNKNOWN American Society of Clinical Oncology
Dec 3, 2011·Acta Neuropathologica·Michael D TaylorStefan M Pfister

❮ Previous
Next ❯

Citations

Jul 10, 1999·Journal of Chromatography. a·J W Cochran, G M Frame
Jun 5, 2013·Translational Oncology·Hye Sook MinSung-Hye Park
Jul 18, 2014·Acta Neuropathologica Communications·Gabriel A Bien-Willner, Robi D Mitra
Aug 9, 2016·Journal of Biotechnology·Delyan P IvanovAnna M Grabowska
Feb 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J H ShihMichael D Taylor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.